Literature DB >> 144056

Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status.

A G Ugazio, S D Jayakar, A F Marcioni, M Duse, V Monafo, F Pasquali, G R Burgio.   

Abstract

The relationship between the presence of hepatitis B surface antigen (HBsAg) and antibodies to human thyroglobulin (HTgAb) has been studied in 110 subjects with Down's syndrome (DS) from 4 months to 50 years of age and in 122 controls carefully matched for sex, age and socio-environmental conditions. The overall percentage of HBsAg carriers was 22.7 in DS and 6.6 in controls and that of HTgAb-positive subjects was 41.8 in DS and 19.7 in controls. In DS the frequency of HTgAb-positive subjects was very high, even in the youngest age groups in which the percentage of HBsAg carriers was relatively low; the latter thereafter showed a marked increase with age. A positive association between the presence of HBsAg and HTgAb was found only in the oldest age group of DS subjects. It is thus concluded that in DS the high frequency of HTgAb cannot be attributed to chronic hepatitis B virus infection. On the contrary, the presence of HTgAb might well represent an early "marker" of immunodeficiency and increased susceptibility to infection with hepatitis B virus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144056     DOI: 10.1007/bf00442195

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  T system immune-deficiency in Down's syndrome.

Authors:  S Levin; E Nir; B M Mogilner
Journal:  Pediatrics       Date:  1975-07       Impact factor: 7.124

2.  Defective antibody response to bacteriophage phichi 174 in Down syndrome.

Authors:  V Lopez; H D Ochs; H C Thuline; S D Davis; R J Wedgwood
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

3.  A survey of childhood malignancies.

Authors:  A STEWART; J WEBB; D HEWITT
Journal:  Br Med J       Date:  1958-06-28

4.  A study of the immunology and biology of mongolism.

Authors:  M DONNER
Journal:  Ann Med Exp Biol Fenn       Date:  1954

5.  Susceptibility of mongoloids to infection; incidence of pneumonia, influenza A and Shigella dysenteriae, Sonne.

Authors:  M SIEGEL
Journal:  Am J Hyg       Date:  1948-07

6.  Down's syndrome and malignancy.

Authors:  D Schuler; M Dobos; G Fekete; T Machay; A Nemeskéri
Journal:  Acta Paediatr Acad Sci Hung       Date:  1972

7.  Mongolism and thyroid autoimmunity.

Authors:  G R Burgio; F Severi; R Rossoni; R Vaccaro
Journal:  Lancet       Date:  1965-01-16       Impact factor: 79.321

8.  Evaluation of a new haemagglutination technique for the demonstration of hepatitis-B antigen.

Authors:  H W Reesink; W J Duimel; H G Brummelhuis
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

9.  Thyroid antibodies and Australia antigen in Down's syndrome.

Authors:  P J Fialkow; B S Blumberg; W T London; A I Sutnick; H C Thuline
Journal:  J Ment Defic Res       Date:  1971-09

10.  Stress deficiency of the T-lymphocyte system exemplified by Down syndrome.

Authors:  S Whittingham; D B Pitt; D L Sharma; I R Mackay
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

View more
  4 in total

1.  Immunity in Down's syndrome.

Authors:  G R Burgio; A G Ugazio
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

2.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

3.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

Review 4.  Immunodeficiency and syndromes: a nosographic approach.

Authors:  G R Burgio; A G Ugazio
Journal:  Eur J Pediatr       Date:  1982-07       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.